Study of XELOX With Cetuximab in Advanced Gastric Cancer
NCT00398398
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Capecitabine, Oxaliplatin, Cetuximab
Sponsor
Asan Medical Center